To create the list, Fortune and management consultancy Korn Ferry sifted through 1,500 top global companies to come up with the top 333. The top 50 companies were ranked through a survey of 3,740 industry experts and placed on an “All-Star” list.
These five healthcare companies were ranked among the 50 All-Stars within Fortune’s list:
- Pfizer (4th)
- Johnson & Johnson (17th)
- CVS Health (27th)
- Danaher (37th)
- Merck (41st)
These 27 companies made in onto the “World’s Most Admired Companies” list but fell outside of the top 50:
Abbott Laboratories
AmerisourceBergen
Amgen
Anthem
Boston ScientificRoche Group
Bristol-Myers Squibb
Cardinal Health
Centene
Charles River Laboratories International
Cigna
DaVita
Eli Lilly
Encompass Health
Fresenius
HCA Healthcare
Henry Schein
Humana
IQVIA Holdings
McKesson
Medtronic
Novartis
Quest Diagnostics
Stryker
Thermo Fisher Scientific
UnitedHealth Group
Universal Health Services
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
